Search research articles
Contact Us
Filters
Showing results (561-570 of 709) with videos related to
Page
of 71
Sort By:
International Journal of Clinical Oncology
|
March 29, 2020
Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802)
Takashi Ohta, Takeshi Kato, Hisato Kawakami, et al.
Targeted Oncology
|
June 17, 2016
Early Tumor Shrinkage and Depth of Response as Predictors of Favorable Treatment Outcomes in Patients with Metastatic Colorectal Cancer Treated with FOLFOX Plus Cetuximab (JACCRO CC-05)
Akihito Tsuji, Yu Sunakawa, Wataru Ichikawa, et al.
Clinical Colorectal Cancer
|
November 19, 2016
Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials
Yu Sunakawa, Wataru Ichikawa, Akihito Tsuji, et al.
Oncology Reports
|
July 6, 2006
Expression of type I interferon receptor as a predictor of clinical response to interferon-alpha therapy of gastrointestinal cancers
Hideo Ota, Hiroaki Nagano, Yuichiro Doki, et al.
Heart and Vessels
|
July 4, 2018
Lower on-treatment platelet reactivity during everolimus-eluting stent implantation contributes to the resolution of post-procedural intra-stent thrombus: serial OCT observation in the PRASFIT-Elective study
Akihide Konishi, Masamichi Iwasaki, Toshiro Shinke, et al.
Molecular Diagnosis & Therapy
|
September 1, 2025
Circulating Tumor DNA Profiling Reveals Genomic Evolution in Recurrent Gastric or Gastroesophageal Junction Cancer
Ryohei Kawabata, Hiroyuki Takeda, Atsushi Ishiguro, et al.
Oncotarget
|
March 17, 2018
Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis
Tatsuo Kanda, Shin Yasui, Masato Nakamura, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
|
February 1, 2019
Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial
Osamu Iida, Kazushi Urasawa, Yasuo Komura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
May 18, 2022
Early P2Y<sub>12</sub> Inhibitor Single Antiplatelet Therapy for High-Bleeding Risk Patients After Stenting - PENDULUM Mono 24-Month Analysis
Yoshihisa Nakagawa, Kazushige Kadota, Koichi Nakao, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
February 15, 2021
Single Antiplatelet Therapy With Prasugrel vs. Dual Antiplatelet Therapy in Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk
Masato Nakamura, Kazushige Kadota, Koichi Nakao, et al.
Page
of 71
Search research articles
Search
Showing results (561-570 of 709) with videos related to
Sort By:
Page
of 71
International Journal of Clinical Oncology
|
March 29, 2020
Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802)
Takashi Ohta, Takeshi Kato, Hisato Kawakami, et al.
Targeted Oncology
|
June 17, 2016
Early Tumor Shrinkage and Depth of Response as Predictors of Favorable Treatment Outcomes in Patients with Metastatic Colorectal Cancer Treated with FOLFOX Plus Cetuximab (JACCRO CC-05)
Akihito Tsuji, Yu Sunakawa, Wataru Ichikawa, et al.
Clinical Colorectal Cancer
|
November 19, 2016
Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials
Yu Sunakawa, Wataru Ichikawa, Akihito Tsuji, et al.
Oncology Reports
|
July 6, 2006
Expression of type I interferon receptor as a predictor of clinical response to interferon-alpha therapy of gastrointestinal cancers
Hideo Ota, Hiroaki Nagano, Yuichiro Doki, et al.
Heart and Vessels
|
July 4, 2018
Lower on-treatment platelet reactivity during everolimus-eluting stent implantation contributes to the resolution of post-procedural intra-stent thrombus: serial OCT observation in the PRASFIT-Elective study
Akihide Konishi, Masamichi Iwasaki, Toshiro Shinke, et al.
Molecular Diagnosis & Therapy
|
September 1, 2025
Circulating Tumor DNA Profiling Reveals Genomic Evolution in Recurrent Gastric or Gastroesophageal Junction Cancer
Ryohei Kawabata, Hiroyuki Takeda, Atsushi Ishiguro, et al.
Oncotarget
|
March 17, 2018
Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis
Tatsuo Kanda, Shin Yasui, Masato Nakamura, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
|
February 1, 2019
Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial
Osamu Iida, Kazushi Urasawa, Yasuo Komura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
May 18, 2022
Early P2Y<sub>12</sub> Inhibitor Single Antiplatelet Therapy for High-Bleeding Risk Patients After Stenting - PENDULUM Mono 24-Month Analysis
Yoshihisa Nakagawa, Kazushige Kadota, Koichi Nakao, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
February 15, 2021
Single Antiplatelet Therapy With Prasugrel vs. Dual Antiplatelet Therapy in Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk
Masato Nakamura, Kazushige Kadota, Koichi Nakao, et al.
Page
of 71